epimedin-c and Diabetes-Mellitus--Type-2

epimedin-c has been researched along with Diabetes-Mellitus--Type-2* in 2 studies

Other Studies

2 other study(ies) available for epimedin-c and Diabetes-Mellitus--Type-2

Article	Year
Construction of Fe International journal of biological macromolecules, 2020, Dec-15, Volume: 165, Issue:Pt A Topics: alpha-Glucosidases; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Ferric Compounds; Flavonoids; Glycoside Hydrolase Inhibitors; Humans; Ligands; Magnetic Iron Oxide Nanoparticles; Tandem Mass Spectrometry	2020
Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents. Molecules (Basel, Switzerland), 2017, Jun-13, Volume: 22, Issue:6 The therapeutic properties of Topics: alpha-Glucosidases; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Epimedium; Flavonoids; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Molecular Docking Simulation; Plant Extracts; Protein Tyrosine Phosphatase, Non-Receptor Type 1	2017

Article

Year

International journal of biological macromolecules, 2020, Dec-15, Volume: 165, Issue:Pt A

Topics: alpha-Glucosidases; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Ferric Compounds; Flavonoids; Glycoside Hydrolase Inhibitors; Humans; Ligands; Magnetic Iron Oxide Nanoparticles; Tandem Mass Spectrometry

2020

Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents.

Molecules (Basel, Switzerland), 2017, Jun-13, Volume: 22, Issue:6

The therapeutic properties of

Topics: alpha-Glucosidases; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Epimedium; Flavonoids; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Molecular Docking Simulation; Plant Extracts; Protein Tyrosine Phosphatase, Non-Receptor Type 1

2017